DSM Venturing

Founded in 2002, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

Rob Beudeker

Investment Director

Casper Bruens

Senior Investment Manager

Marcel Kloosterman

Investment Manager

Pieter Wolters

Managing Director

77 past transactions

VitaminLab

Series A in 2023
VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry.

Athian

Seed Round in 2023
At Athian, we are technology experts with farming in our genes. We enable environmental sustainability for animal agriculture because we believe in being good stewards of the economic and environmental health of farms and the communities surrounding them. We use software to aggregate, certify, and fund greenhouse gas reduction plans throughout the entire livestock value-chain. Athian’s key mission is to help the beef and dairy value chains capture and claim carbon credits earned through sustainability efforts by aggregating, verifying, and certifying greenhouse gas (GHG) reductions, and monetizing those reductions for the producer through the sale of carbon insetting credits. Athian’s platform is an industry-based analytics tool that provides quality greenhouse gas credits that fund livestock producers’ sustainability measures. Athian is a High Alpha Innovation company based in Indianapolis, Indiana, and is funded by industry leaders Elanco Aniimal Health, DSM-Firmenich, Newtrient LLC., Tyson Ventures, and California Dairies (CDI). Learn how to join us in this effort at www.athian.ag

Meala Foodtech

Pre Seed Round in 2023
Meala Foodtech develops functional proteins for multiple meat replacements. Meala uses naturally occurring biocatalysts to treat plant-based proteins.

Rootine

Series A in 2022
Take control of your health and achieve your full potential with Rootine. We use technology to connect the dots between your health data and nutrition solutions that work for you. We first help you understand what your body needs to perform optimally and then provide the solutions to help you get there through precision lab tests and wearable analytics, nutrients, and guidance. Your Rootine dashboard enables you to track progress, and our data-first approach helps fine-tune your recommendations and nutrient formulas over time as your body changes. Whether you are a seasoned athlete or just starting to think about your health, Rootine is for you. Get started today and join our community of thousands of members who have gained confidence and improved their energy, stress, productivity, performance and total body health. www.rootine.co

Phytolon

Series A in 2022
Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability

Chinova Bioworks

Series A in 2022
Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

inne

Series A in 2022
Inne is a Berlin-based biotech startup that builds a hormone-based mini lab for women with a mission to make natural contraception convenient and accurate. They aim to help women tune into their bodies and make informed decisions about their fertility and overall female health. Inne uses biochemistry and an app to track hormones and understand what it means and how they affect a woman's everyday fertility.

OK Capsule

Seed Round in 2022
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

ATRO Medical

Venture Round in 2021
ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise has created the base for the Trammpolin design and the development towards a prototype.

OK Capsule

Seed Round in 2021
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

Rootine

Seed Round in 2021
Take control of your health and achieve your full potential with Rootine. We use technology to connect the dots between your health data and nutrition solutions that work for you. We first help you understand what your body needs to perform optimally and then provide the solutions to help you get there through precision lab tests and wearable analytics, nutrients, and guidance. Your Rootine dashboard enables you to track progress, and our data-first approach helps fine-tune your recommendations and nutrient formulas over time as your body changes. Whether you are a seasoned athlete or just starting to think about your health, Rootine is for you. Get started today and join our community of thousands of members who have gained confidence and improved their energy, stress, productivity, performance and total body health. www.rootine.co

Prenexus Health

Series B in 2021
Prenexus Health is a prebiotic ingredient manufacturer focused on digestive health and wellness through the research, development and production of branded prebiotic ingredients for vitamin, dietary supplement, food and beverage products. As a science-based company, Prenexus Health is an innovative global leader in prebiotics supported by scientific and clinical research with an emphasis in digestive and microbiome health.

Inkbit

Series B in 2021
Inkbit creats a next-generation additive manufacturing platform that combines 3D printing with machine vision. MIT-trained scientists and engineers combines expertise in industrial systems, design software, and material science to identify and seize opportunities for mass-market additive manufacturing.

Leading Edge Equipment Technologies

Convertible Note in 2021
Leading Edge Crystal Technologies is a developer of kerfless, single crystal silicon wafers intended to be used in solar panels with higher efficiency and lower cost that fit into existing module manufacturing processes without any changes.

Brains Bioceutical

Series A in 2021
Brains Bioceutical engages in GMP – certified production of naturally sourced active pharmaceutical ingredients (APIs) for the pharmaceutical and nutraceutical industries.

Meatable

Series A in 2021
Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from an animal, allowing consumers to have sustainable food.

Deep Branch Biotechnology

Series A in 2021
Deep Branch uses clean and renewable carbon and energy to create ingredients for a more sustainable food system. With a customer-focused research and development pipeline, it can quickly deliver high-quality, next-generation bio-based products to meet society’s demand for food and feed sustainably. By collaborating with local providers of strategic raw materials, Deep Branch can identify the best sites that offer sustainable input supply while helping develop the local economy. The company’s proprietary gas fermentation platform also uses sustainable and scalable feedstocks, strengthening its competitive edge in the global food and feed ingredients markets. Deep Branch has established strong partnerships across the value chain as it deploys its gas fermentation platform with a clear scale-up roadmap backed by world-leading investors and strategic partners. It also has a proven track record of integrating with carbon dioxide suppliers to deploy its technology efficiently and safely. Combining entrepreneurial drive with industrial experience, Deep Branch’s scientists and engineers produce ground-breaking innovations to meet market demand. Creating locally-produced ingredients with up to 60% smaller carbon footprints than traditional alternatives means Deep Branch’s products require no arable land and minimal water. With benefits such as these, the company is tackling the climate crisis and addressing biodiversity loss by helping secure the future of the global food system without consumers compromising on nutrition or quality.

Novum Medical

Venture Round in 2021
Novum Medical designs innovative orthopedic implants using novel biomaterials to provide an enhanced interface between the implant and bone to allow for a more natural healing process and improved performance. The materials and implant technologies under evaluation have broad applications in the musculoskeletal system.

Frontier Nutrition

Series B in 2021
Frontier Nutrition develops, manufacture, and markets packaged food products. Their products and strategies are based on research in pediatric nutrition and behavioral marketing. Their recipes are localized for traditional diets and optimized for taste, nutrition, and price. Frontier Nutrition, Inc. was founded in 2017 by Eddie Bearnot and Tanveer Ali and is based in New Haven, Connecticut, United States.
Leading Edge Crystal Technologies is a developer of kerfless, single crystal silicon wafers intended to be used in solar panels with higher efficiency and lower cost that fit into existing module manufacturing processes without any changes.

NutriLeads

Series B in 2020
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific and clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

Phynova Group

Venture Round in 2020
Phynova is a British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants. Founded in 2002, Phynova is an innovative life science company based in Oxford, UK with a subsidiary research company located in Beijing, China. Phynova develops and commercialises natural healthcare products derived from active compounds found in plants. Phynova develops products for use in global healthcare and FMCG markets. It identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops solutions for global health concerns.

Panaceutics Nutrition

Series A in 2020
Panaceutics Nutrition is a company that produces individually customized smoothies with proprietary cost-effective robotic technology. The company was founded in 2018 by Edison Hudson and Staton Noel and is based in Ringgold, Virginia, United States.

Inkbit

Venture Round in 2019
Inkbit creats a next-generation additive manufacturing platform that combines 3D printing with machine vision. MIT-trained scientists and engineers combines expertise in industrial systems, design software, and material science to identify and seize opportunities for mass-market additive manufacturing.

Voxel8

Series B in 2019
Voxel8 has developed a unique digital 3D printing technology that can zonally tune the mechanical properties of textiles, add 3D embellishments and aesthetic features. The technology is broadly applicable in textile applications from footwear uppers, apparel (bras, gloves, leggings), medical (orthotic braces, wearables), wall coverings, seat covers, branded goods and fashion articles. Key benefits of the technology are the ability to customize each individual print, tailoring the performance and aesthetic of the textile to the individual or application. Voxel8 uses an additive process (less waste) and have developed a 65 % bio-based material set to further reduce the carbon footprint. They can impact the functional performance of textiles making them more abrasion resistant, adding support or impact resistance, cushioning elements or grip features. At the same time they can digitally add 3D embellishments and color. The technology was developed in Professor Jennifer Lewis' Lab at the School of Engineering and Applied Sciences at Harvard University.
AMT has developed is a automated technology platform called PostPro that delivers an order of magnitude improvement in cost, quality, safety, and throughput in the manufacturing of 3D printed parts.AMT has developed an automated post-production technology platform called PostPro. PostPro automates the manual and costly steps associated with legacy additive .

Chinova Bioworks

Seed Round in 2019
Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

Panaceutics Nutrition

Venture Round in 2019
Panaceutics Nutrition is a company that produces individually customized smoothies with proprietary cost-effective robotic technology. The company was founded in 2018 by Edison Hudson and Staton Noel and is based in Ringgold, Virginia, United States.

Hyalex Orthopaedics

Series A in 2019
Hyalex Orthopaedics is a Lexington, MA medical device company advancing new products that feature HYALEX™ materials technology, a polymer that is designed to mimic cartilage. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics' products are in the development stage and have not been approved for use in humans by any regulatory agency.

Adaptive3D

Series A in 2019
Adaptive3D is a leading supplier of premium additive manufacturing polymer resins, focusing on enabling high-volume production through optimized materials. The company specializes in rubber-like 3D printable materials, damping materials, and low-cure stress photopolymers. By leveraging innovative technologies, Adaptive3D provides high-quality polymer resins and specialty polymers that empower clients to create differentiated products with exceptional part performance. Their solutions are designed for both functional end-use products and prototypes, allowing for precise internal geometries and economically customized parts. Through partnerships with global leaders, Adaptive3D is committed to advancing the capabilities of additive manufacturing.

Raycatch

Series B in 2018
Raycatch is an AI diagnostics technology for solar energy, on a mission to revolutionize the PV market by enabling automated management of solar assets. By deciphering existing solar energy data, Raycatch transforms PV Operation and Maintenance (O&M) tasks from traditional manual scheduled operations to on-demand automatic management. The Raycatch app, DeepSolar™, analyzes production data on a daily basis and aims to generate a full diagnostic mapping of all components in a PV portfolio. All insights are ROI driven and fully quantified, include panels under warranty but below the spec, maintenance on demand (dust + grass), disconnected cables, PID, temperature coefficient, MPPT/Inverter efficiency, tracking systems and many more. The result is maximized performance and maintenance of solar assets, leading to increased yield, decreased operational costs and the acceleration of solar energy penetration in the global energy market. No hardware or software installation, No site visits are needed.

Miach Orthopaedics

Series A in 2018
Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury. Miach Orthopaedics was founded on 2016 and is headquartered in Westborough, Massachusetts.

Novum Medical

Series C in 2018
Novum Medical designs innovative orthopedic implants using novel biomaterials to provide an enhanced interface between the implant and bone to allow for a more natural healing process and improved performance. The materials and implant technologies under evaluation have broad applications in the musculoskeletal system.

Chinova Bioworks

Seed Round in 2018
Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

Chromatic 3D Materials

Series A in 2018
Chromatic 3D Materials is inventing the next generation of 3D printing materials with the durability to meet the requirements for finished manufactured goods. Today, their reality includes infinite possibilities for novel product designs, made possible by their customizable property range.

Tespo

Series A in 2018
Tespo manufactures a liquid vitamin dispenser helping individuals with health goals. The company's system provides all the storage, convenience, and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives, or unnecessary ingredients.
Leading Edge Crystal Technologies is a developer of kerfless, single crystal silicon wafers intended to be used in solar panels with higher efficiency and lower cost that fit into existing module manufacturing processes without any changes.

ATRO Medical

Series A in 2017
ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise has created the base for the Trammpolin design and the development towards a prototype.

NutriLeads

Series A in 2017
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific and clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

QD Solar

Series A in 2017
The solar photovoltaic market is one of the fastest growing energy markets in the world. That growth comes amidst the race to the bottom on cell and module pricing driven by fierce supply side market competition. PV manufacturers can no longer count on economies of scale and incremental process improvements to attain profit in the face of competitive pricing pressures. Manufacturers need to differentiate their product by delivering better performance for the same or lower cost. QD Solar, a University of Toronto spinoff company, will provide this differentiation.

WattGlass

Series A in 2017
WattGlass is a startup company based in Fayetteville, Arkansas. The company was founded to commercialize a novel nanoparticle glass coating developed at the University of Arkansas. The coating technology was invented by our CEO during his PhD research at the University of Arkansas and WattGlass has secured an exclusive license and overseen the filing of a PCT patent application in March 2014. The ongoing research at WattGlass has resulted in the development of additional patent filings related to our core technology.

Essential Medical

Series B in 2016
Essential Medical, Inc. has developed two femoral artery closure devices intended to seal femoral punctures following vascular access medical procedures requiring a cardiac catheterization. MANTA is designed to close large bore punctures (10-24F) following procedures such as transcatheter aortic valve replacement (TAVR), abdominal aortic aneurysm repair (AAA/PVAR), and balloon aortic valvuloplasty (BAV). These procedures are one of the fastest growing segments within interventional cardiology.

Blue Prairie

Series A in 2016
Blue Prairie Brands is introducing innovative ingredients and related food products rich in prebiotics, which in conjunction with probiotics, help maintain a healthy digestive system. It's flagship product is rich in the prebiotic inulin, yet Blue Prairie Brands delivers it in a whole-food, gluten-free, non-GMO form. The Company's proprietary approach to production also provides farmers a profitable rotation crop that utilizes their existing equipment and experience.

Arecor

Venture Round in 2016
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

NOMADD

Series A in 2016
The NOMADD is The NO-water Mechanical Automated Dusting Device. It was developed at the King Abdullah University for Science and Technology, (KAUST) near Jeddah, Saudi Arabia.

NutriLeads

Seed Round in 2015
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific and clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

NovoPolymers

Venture Round in 2015
NovoPolymers NV is a company, with the vision and mission to develop and produce sustainable solutions for primarily the photovoltaic market.

Natreon

Venture Round in 2015
Natreon, Inc.is a company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property.

Interface Biologics

Series B in 2015
Interface Biologics, Inc. (IBI) is a commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. Their patent-protected technologies include anti-thrombogenic additives for blood contacting medical devices and polymer enabled combination drug delivery devices. IBI has exclusive Endexo™ technology licensing agreements with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic dialysis systems. AngioDynamics’ BioFlo PICCS, Ports and DuraMax Dialysis Catheter with IBI’s Endexo technology have received FDA clearance and are gaining commercial traction. IBI also has a joint venture commercial agreement with Qualimed to develop a drug-coated balloon based on IBI’s Kinesyx™ technology. The company was founded in 2001 and is headquartered in Toronto, Canada at the acclaimed MaRS Innovation Centre.

EyePromise

Venture Round in 2014
EyePromise manufactures and sells zeaxanthin dietary supplements for those at risk of age-related vision loss. It offers QuantifEYE program for assessing risk of developing age-related macular degeneration; EyePromise restore, a professional dietary supplement; and EyePromise ten-for those who prefer xeaxanthin supplement.

Isobionics

Venture Round in 2014
Isobionics is a company that uses a proprietary biotechnology process for the production of flavor and fragrance ingredients. Its focus is on isoprenoid-based products for food, beverage, flavor and fragrance markets. The biotechnology process delivers products with higher quality and purity, at lower production cost.

ChromaDex

Post in 2013
ChromaDex is a global nutraceutical company. They leverage their complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. They utilize in-house chemistry, regulatory, and safety consulting business units to develop commercially viable ingredients.

Arecor

Venture Round in 2013
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

Segetis

Series C in 2012
Segetis, Inc., a green chemistry company, engages in the development, production, and commercialization of renewable polymers. The company focuses on a platform of binary monomers based on renewable feed stocks. The company's technology enables the use of non-food agricultural and forestry feed stocks for the production of various materials, as well as enables the second wave of industrial bioproducts, such as bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other compounds for specialty chemical applications. Its chemistries offer various opportunities for product enablement and synergies for industries engaged in the processing of starch and sugar crops; processing of wood, cellulose, and paper pulp; chemical processing of vegetable oils; manufacturing of biodiesel; and the manufacturing of linear alpha-olefins and other compounds. The company was founded in 2006 and is based in Golden Valley, Minnesota.

Xolve

Funding Round in 2012
Xolve is an early stage company commercializing IP that enables effective, simple, room temperature processing of graphene and other nanoparticle composites, solutions and coatings.

Regentis Biomaterials

Series C in 2012
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The company’s core technology is a iodegradable hydrogel called Gelrin™. It is based on polyethylene glycol diacrylate and denatured fibrinogen originally developed at the Technion University by Dr. Dror Seliktar. The Gelrin hydrogel platform combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications and has undergone extensive preclinical and safety testing over the last few years. The company’s flagship product, GelrinC™,designed for the treatment of articular cartilage lesions, is currently in clinical trials.

Verdezyne

Venture Round in 2011
Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.

CellMade

Funding Round in 2010
CellMade develops and commercializes cell biology products and services: human-origin primary cells, co-culture models, customized cell isolation and characterization. CellMade also invests in its own R&D program using its CellInsight platform for identification of targets and biomarkers related to inflammatory pathologies. The company has facilities in Marseille (France) and at the Chemelot Campus.

Segetis

Series B in 2010
Segetis, Inc., a green chemistry company, engages in the development, production, and commercialization of renewable polymers. The company focuses on a platform of binary monomers based on renewable feed stocks. The company's technology enables the use of non-food agricultural and forestry feed stocks for the production of various materials, as well as enables the second wave of industrial bioproducts, such as bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other compounds for specialty chemical applications. Its chemistries offer various opportunities for product enablement and synergies for industries engaged in the processing of starch and sugar crops; processing of wood, cellulose, and paper pulp; chemical processing of vegetable oils; manufacturing of biodiesel; and the manufacturing of linear alpha-olefins and other compounds. The company was founded in 2006 and is based in Golden Valley, Minnesota.

Novomer

Series B in 2009
Novomer is a new materials company pioneering a family of competitively priced high-performance green plastics, polymers and other chemicals. With proprietary catalytic technology and a world-class scientific team, Novomer's groundbreaking technology allows carbon dioxide and other renewable materials to be cost-effectively transformed into polymers, plastics and other chemicals for a wide variety of industrial markets. It was founded in 2004 and headquartered in Waltham, Massachusetts.

Viocare

Venture Round in 2009
Viocare, Inc. is a privately-held company bringing the benefits of cutting edge knowledge in the nutrition and behavior change sciences to the development of breakthrough web and mobile solutions that serve both researchers and the preventive care market.

Provexis

Post in 2008
Provexis plc is engaged in developing and licensing the Fruitflow heart-health functional food ingredient for the global functional food sector.

Ganeden Biotech

Venture Round in 2007
Ganeden Biotech was founded in 1997 out of a desire to develop superior strains of probiotics which break down the barriers inherent to most common strains of probiotics. Simply put, Ganeden is a science driven organization dedicated to bringing superior probiotics to markets that have otherwise been unmet by traditional solutions. Through dedication to our mission, "Improving Quality of Life" They are driven to develop solutions that are safe and effective. In 2003 Ganeden launched a popular line of over-the-counter products under brand names such as Digestive Advantage, Clearly Confident and Sustenex. Since launching the consumer product line in 2003 Ganeden' has sold nearly 200 million doses of its products through over 40,000 retail outlets.

Upfront Chromatography

Venture Round in 2007
Upfront Chromatography is a Denmark-based biotech company with significant expertise and regulatory experience in the development of customised industrial processes. Upfront develops and manufactures innovative products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells, directly from bioreactors and industrial side-streams.

Harland Medical Systems

Private Equity Round in 2007
Increasing the value of healthcare products with integrated surface enhancement solutions Harland Medical Systems was founded in 2003 in Minnesota, USA to bring total solutions to the emerging healthcare surface enhancement market. Since that time we have dozens of successful customer installations under our belt, ranging in industry market segments from Neurology to Urology and Cardiology to Wound care, Peripheral, Micro-plate, Ophthalmic, Endoscopic and many others.

Micromuscle

Venture Round in 2006
Micromuscle AB was founded in 2000 to develop innovative biomedical products based on the company's proprietary electroactive polymer technology-MICROMUSCLE technology. Micromuscle's proprietary technology relates to electroactive polymers which are capable of expanding and contracting when subjected to an electric potential.

IntegraGen

Venture Round in 2006
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

Sciona

Series C in 2006
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

ORYXE Energy International

Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.

Morphotek

Series C in 2004
Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Optiva

Series C in 2003
Optiva is mission-critical, cloud-native monetization and revenue management software on the private and public cloud. It is recognized by the industry for its disruptive and innovative approach beyond the cloud. Operators that leverage solutions gain the freedom to experiment with new capabilities with speed and agility. The result is the rapid introduction of new customer offerings services and commercial models to accelerate their business velocity.

Sciona

Series A in 2002
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.